Coronavirus: COVID 19- Vaccine & Treatment (Recovering Patients) - Free Job Alert 2020 | Rozgaar Express

Monday, 23 March 2020

Coronavirus: COVID 19- Vaccine & Treatment (Recovering Patients)


Only discovered coroner virus causes coroner virus disease covert 19 a coroner virus outbreak began in China but is rapidly spreading around the globe and on March 11th World Health Organization declared covert 19 as a pandemic every case of covert 19 leads to roughly two-point-three new cases meaning the outbreak is still spreading the causative agent for this outbreak is named a SARS Co v2 severe acute respiratory syndrome coronavirus.

According to World Health Organization as of March 17, 2020, there has been one lakh 82,000 629 cases of covert 19and 7601 deaths at such time it is crucial to note that about 26% of the patients have recovered and most of the patients will recover soon patients are discharged after clinical recovery with no symptoms and to negative PCR tests taken 24 hours apart upon discharge they are asked to minimize family and social contacts and to wear a mask in China the overall CFR was higher in the early stages of the outbreak which is 17.3% which reduced over time to 0.7% by February 1st this means that with proper control the condition can be stabilized also we must note that the mortality rate for Koh vat19 differs by groups that are if.

We consider different age groups then the fatality rate is relatively lower for individuals below 60 years however the fatality rate climbs up for the elderly so the highest risk group is individuals above 60 years also it has been noted that individuals with hypertension diabetes cardiovascular diseases chronic respiratory diseases and cancer show a high fatality rate compared to healthy individuals usually the elderly group suffers from one or more of these conditions the goal right now is to flatten the curve social distancing measures like self-isolation sanitization closure of schools or workplaces and reduction in person-to-person contact will help in flattening the curve currently World Health Organization published a draft of 41 candidate vaccines in the pre-clinical trial also.

Today Kaiser Permanente Washington Health Research Institute in Seattle is conducting a human trial funded by the National Institutes of Health it includes 45 young healthy volunteers who will receive different doses of the vaccine that was co-developed by the NIH and modern a covert 19 patient after recovery can have blood drawn and screened for Tsarskoe v2 neutralizing antibodies this serum can be used as a vaccine for high-risk group or as a treatment measure with many patients recovering from the disease this treatment method may be successful meanwhile.

It is crucial to have a highly sensitive and accurate diagnostic tool that will help us to catch every single case of covert 19:10 kits based on rt-PCR isothermal amplification virus sequencing and colloidal gold activity are being widely used for detection serological Diagnostics are rapidly being developed that are not yet widely used proper detection would mean that fewer CO vat19 patients are sent back home to suffer from the disease and eventually spread it to others typical signs and symptoms include fever dry cough fatigue sputum production shortness of breath sore throat headache myalgia arthralgia chills nausea or vomiting nasal congestion diarrhea hemat Isis and conjunctival congestion please get diagnosed if you suffer from these symptoms and stay safe.